Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' WALPORT MJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 112 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Samarkos, M; Davies, KA; Gordon, C; Walport, MJ; Loizou, S
      IgG subclass distribution of antibodies against beta(2)-GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associations

      RHEUMATOLOGY
    2. Mabbott, NA; Bruce, ME; Botto, M; Walport, MJ; Pepys, MB
      Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie

      NATURE MEDICINE
    3. Klein, MA; Kaeser, PS; Schwarz, P; Weyd, H; Xenarios, I; Zinkernagel, RM; Carroll, MC; Verbeek, JS; Botto, M; Walport, MJ; Molina, H; Kalinke, U; Acha-Orbea, H; Aguzzi, A
      Complement facilitates early prion pathogenesis

      NATURE MEDICINE
    4. Robson, MG; Walport, MJ
      Pathogenesis of systemic lupus erythematosus (SLE)

      CLINICAL AND EXPERIMENTAL ALLERGY
    5. Pickering, MC; Botto, M; Taylor, PR; Lachmann, PJ; Walport, MJ
      Systemic lupus erythematosus, complement deficiency, and apoptosis

      ADVANCES IN IMMUNOLOGY, VOL. 76
    6. Walport, MJ
      Advances in immunology: Complement (Second of two parts).

      NEW ENGLAND JOURNAL OF MEDICINE
    7. Walport, MJ
      Advances in immunology: Complement (First of two parts).

      NEW ENGLAND JOURNAL OF MEDICINE
    8. Pickering, MC; Fischer, S; Lewis, MR; Walport, MJ; Botto, M; Cook, HT
      Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    9. Petry, F; Botto, M; Holtappels, R; Walport, MJ; Loos, M
      Reconstitution of the complement function in C1q-deficient (C1qa(-/-)) mice with wild-type bone marrow cells

      JOURNAL OF IMMUNOLOGY
    10. Haywood, MEK; Vyse, TJ; McDermott, A; Thompson, EM; Ida, A; Walport, MJ; Izui, S; Morley, BJ
      Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone BXSB mice

      JOURNAL OF IMMUNOLOGY
    11. Robson, MG; Cook, HT; Botto, M; Taylor, PR; Busso, N; Salvi, R; Pusey, CD; Walport, MJ; Davies, KA
      Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice

      JOURNAL OF IMMUNOLOGY
    12. Manderson, AP; Pickering, MC; Botto, M; Walport, MJ; Parish, CR
      Continual low-level activation of the classical complement pathway

      JOURNAL OF EXPERIMENTAL MEDICINE
    13. Taylor, PR; Seixas, E; Walport, MJ; Langhorne, J; Botto, M
      Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites

      INFECTION AND IMMUNITY
    14. Cutler, AJ; Cornall, RJ; Ferry, H; Manderson, AP; Botto, M; Walport, MJ
      Intact B cell tolerance in the absence of the first component of the classical complement pathway

      EUROPEAN JOURNAL OF IMMUNOLOGY
    15. Vandiver, RW; Botto, M; Taylor, PL; Ogden, CA; Fadok, VA; Walport, MJ; Henson, PM
      Homozygous C1qa deficiency alters pulmonary clearance of apoptotic cells

      CHEST
    16. Nash, JT; Taylor, PR; Botto, M; Norsworthy, PJ; Davies, KA; Walport, MJ
      Immune complex processing in C1q-deficient mice

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    17. Holt, DS; Botto, M; Bygrave, AE; Hanna, SM; Walport, MJ; Morgan, BP
      Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria

      BLOOD
    18. Loizou, S; Samarkos, M; Norsworthy, PJ; Cazabon, JK; Walport, MJ; Davies, KA
      Significance of anticardiolipin and anti-beta(2)-glycoprotein I antibodiesin lupus nephritis

      RHEUMATOLOGY
    19. Pickering, MC; Walport, MJ
      Links between complement abnormalities and systemic lupus erythematosus

      RHEUMATOLOGY
    20. Walport, MJ
      Lupus, DNase and defective disposal of cellular debris

      NATURE GENETICS
    21. Topaloglu, R; Bakkaloglu, A; Slingsby, JH; Aydintug, O; Besbas, N; Saatci, U; Walport, MJ
      Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    22. Maibaum, MA; Haywood, MEK; Walport, MJ; Morley, BJ
      Lupus susceptibility loci map within regions of BXSB derived from the SB/Le parental strain

      IMMUNOGENETICS
    23. Taylor, PR; Carugati, A; Fadok, VA; Cook, HT; Andrews, M; Carroll, MC; Savill, JS; Henson, PM; Botto, M; Walport, MJ
      A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

      JOURNAL OF EXPERIMENTAL MEDICINE
    24. Perraudeau, M; Taylor, PR; Stauss, HJ; Lindstedt, R; Bygrave, AE; Pappin, DJC; Ellmerich, S; Whitten, A; Rahman, D; Canas, B; Walport, MJ; Botto, M; Altmann, DM
      Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice

      EUROPEAN JOURNAL OF IMMUNOLOGY
    25. Haywood, MEK; Hogarth, MB; Slingsby, JH; Rose, SJ; Allen, PJ; Thompson, EM; Maibaum, MA; Chandler, P; Davies, KA; Simpson, E; Walport, MJ; Morley, BJ
      Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice

      ARTHRITIS AND RHEUMATISM
    26. Naughton, MA; Battaglia, E; O'Brien, S; Walport, MJ; Botto, M
      Identification of thiopurine methyltransferase (TPMT) polymorphisms cannotpredict myelosuppression in systemic lupus erythematosus patients taking azathioprine

      RHEUMATOLOGY
    27. Bickerstaff, MCM; Botto, M; Hutchinson, WL; Herbert, J; Tennent, GA; Bybee, A; Mitchell, DA; Cook, HT; Butler, PJG; Walport, MJ; Pepys, MB
      Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

      NATURE MEDICINE
    28. Norsworthy, PJ; Taylor, PR; Walport, MJ; Botto, M
      Cloning of the mouse homolog of the 126-kDa human C1q/MBL/SP-A receptor, C1qR(p)

      MAMMALIAN GENOME
    29. Mitchell, DA; Taylor, PR; Cook, HT; Moss, J; Bygrave, AE; Walport, MJ; Botto, M
      Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation

      JOURNAL OF IMMUNOLOGY
    30. Norsworthy, P; Theodoridis, E; Botto, M; Athanassiou, P; Beynon, H; Gordon, C; Isenberg, D; Walport, MJ; Davies, KA
      Overrepresentation of the Fc gamma receptor type IIA R131/R131 genotype inCaucasoid systemic lupus erythematosus patients with autoantibodies to C1qand glomerulonephritis

      ARTHRITIS AND RHEUMATISM
    31. BOTTO M; DELLAGNOLA C; BYGRAVE AE; THOMPSON EM; COOK HT; PETRY F; LOOS M; PANDOLFI PP; WALPORT MJ
      HOMOZYGOUS C1Q DEFICIENCY CAUSES GLOMERULONEPHRITIS ASSOCIATED WITH MULTIPLE APOPTOTIC BODIES

      Nature genetics
    32. WALPORT MJ; DAVIES KA; BOTTO M
      CLQ AND SYSTEMIC LUPUS-ERYTHEMATOSUS

      Immunobiology
    33. ROBSON MG; COOK HT; BOTTO M; PUSEY CD; WALPORT MJ; DAVIES KA
      ACCELERATED NEPHROTOXIC NEPHRITIS - INCREASED SEVERITY OF DISEASE IN CLQ DEFICIENT MICE

      Molecular immunology
    34. ROBSON MG; COOK HT; BOTTO M; PUSEY CD; WALPORT MJ; DAVIES KA
      DELAYED RESOLUTION OF INFLAMMATION IN HETEROLOGOUS NEPHROTOXIC NEPHRITIS IN CLQ DEFICIENT MICE

      Molecular immunology
    35. DAVIES KA; ROBSON M; NASH J; PETERS AM; WALPORT MJ
      IMMUNE-COMPLEX CLEARANCE IS DEFECTIVE IN PATIENTS WITH SLE

      Molecular immunology
    36. MITCHELL TJ; VAISHNAW AK; ROSE J; WALPORT MJ; MORLEY BJ
      TRANSCRIPTIONAL REGULATION OF THE HUMAN C4 GENE

      Molecular immunology
    37. MORLEY BJ; BARTOK I; SPATH PJ; VYSE TJ; SCHNEIDER PM; WALPORT MJ
      MOLECULAR-BASIS OF HEREDITARY FACTOR-I DEFICIENCY

      Molecular immunology
    38. CUTLER AJ; BOTTO M; VANESSEN D; DAVIES KA; GRAY D; WALPORT MJ
      T-CELL-DEPENDENT IMMUNE-RESPONSE IN CLQ DEFICIENT MICE - DEFECTIVE IFN-GAMMA PRODUCTION BY ANTIGEN-SPECIFIC T-CELLS

      Molecular immunology
    39. WARREN J; BOTTO M; MASTROENI P; DOUGAN G; COHEN J; WALPORT MJ
      INCREASED SUSCEPTIBILITY OF CLQ AND BF C2-DEFICIENT MICE TO SALMONELLA INFECTION/

      Molecular immunology
    40. TAYLOR PR; BOTTO M; SEIXAS E; PACKWOOD L; LANGHORNE J; WALPORT MJ
      IMPAIRED CLEARANCE OF MALARIAL PARASITES BY CLQ-DEFICIENT MICE IS ASSOCIATED WITH AN AUGMENTED IFN-GAMMA RESPONSE

      Molecular immunology
    41. HOGARTH MB; SLINGSBY JH; ALLEN PJ; THOMPSON EM; CHANDLER P; DAVIES KA; SIMPSON E; MORLEY BJ; WALPORT MJ
      MULTIPLE LUPUS SUSCEPTIBILITY LOCI MAP TO CHROMOSOME-1 IN BXSB MICE

      The Journal of immunology (1950)
    42. VAISHNAW AK; MITCHELL TJ; ROSE SJ; WALPORT MJ; MORLEY BJ
      REGULATION OF TRANSCRIPTION OF THE TATA-LESS HUMAN-COMPLEMENT COMPONENT C4 GENE

      The Journal of immunology
    43. CUTLER AJ; BOTTO M; VANESSEN D; RIVI R; DAVIES KA; GRAY D; WALPORT MJ
      T-CELL-DEPENDENT IMMUNE-RESPONSE IN C1Q-DEFICIENT MICE - DEFECTIVE INTERFERON-GAMMA PRODUCTION BY ANTIGEN-SPECIFIC T-CELLS

      The Journal of experimental medicine
    44. TAYLOR PR; NASH JT; THEODORIDIS E; BYGRAVE AE; WALPORT MJ; BOTTO M
      A TARGETED DISRUPTION OF THE MURINE COMPLEMENT FACTOR-B GENE RESULTING IN LOSS OF EXPRESSION OF 3 GENES IN CLOSE PROXIMITY, FACTOR-B, C2, AND D17H6S45

      The Journal of biological chemistry
    45. LOIZOU S; SAMARKOS M; NORSWORTHY P; WALPORT MJ; DAVIES KA
      MEASUREMENT OF IGG ANTICARDIOLIPIN AND ANTI-BETA(2)GP1 SUBCLASSES DIFFERENTIATE SLE FROM PAPS PATIENTS

      Arthritis and rheumatism
    46. BICKERSTAFF MCM; BOTTO M; COOK T; MITCHELL D; TENNENT GA; WALPORT MJ; PEPYS MB
      ANTINUCLEAR AUTOIMMUNITY IN MICE WITH TARGETED DELETION OF SERUM AMYLOID-P COMPONENT

      Arthritis and rheumatism
    47. MARGUERIE C; BUNN CC; BLACK CM; SO AK; WALPORT MJ
      ANTI-PL-4 IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS WITH SEVERE RENAL AND HEMATOLOGICAL DISEASE

      Quarterly Journal of Medicine
    48. BOTTO M; HAWKINS PN; BICKERSTAFF MCM; HERBERT J; BYGRAVE AE; MCBRIDE A; HUTCHINSON WL; TENNENT GA; WALPORT MJ; PEPYS MB
      AMYLOID DEPOSITION IS DELAYED IN MICE WITH TARGETED DELETION OF THE SERUM-AMYLOID-P COMPONENT GENE

      Nature medicine
    49. WALPORT MJ; TAYLOR PR
      IMMUNOLOGY - WHAT IS THE PROXIMAL CAUSE OF INFLAMMATION

      Current biology
    50. THOMPSON GR; SCOTT J; WALPORT MJ; OAKLEY CM; HUGHES JMB; BULPITT CJ; TAYLORROBINSON SD
      GRAND ROUNDS - HAMMERSMITH-HOSPITAL - HAZARDS OF RUNNING A MARATHON -CREATINE-KINASE MB CAN BE RAISED WITHOUT MYOCARDIAL-INFARCTION

      BMJ. British medical journal
    51. TAYLOR PR; SLINGSBY JH; WALPORT MJ; BOTTO M
      MURINE D17H6S45 (RD) GENE - POLYMORPHISM AND OVERLAP WITH COMPLEMENT FACTOR-B

      Mammalian genome
    52. SLINGSBY JH; HOGARTH MB; WALPORT MJ; MORLEY BJ
      POLYMORPHISM IN THE LY-17 ALLOANTIGENIC SYSTEM OF THE MOUSE FCGRII GENE

      Immunogenetics
    53. BOTTO M; DELLAGNOLA C; PANDOLFI PP; BYGRAVE A; THOMPSON M; PETRY F; LOOS M; WALPORT MJ
      HOMOZYGOUS C1Q DEFICIENCY - A CAUSE OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN HUMANS AND MICE

      Arthritis and rheumatism
    54. DAVIES KA; NASH J; NORSWORTHY P; DELLAGNOLA C; PETERS AM; WALPORT MJ
      MODEL IMMUNE-COMPLEXES WITH FIX COMPLEMENT POORLY ARE CLEARED PRIMARILY IN THE LIVER IN MAN

      Arthritis and rheumatism
    55. DAVIES KA; NORSWORTHY PJ; ATHANASSIOU P; WALPORT MJ
      ANTI-C1Q ANTIBODIES ACTIVATE COMPLEMENT AND MAY BE PATHOGENIC IN SLE

      Arthritis and rheumatism
    56. LOIZOU S; CAZABON JK; WALPORT MJ; TAIT D; SO AK
      SIMILARITIES OF SPECIFICITY AND COFACTOR DEPENDENCE IN SERUM ANTIPHOSPHOLIPID ANTIBODIES FROM PATIENTS WITH HUMAN PARVOVIRUS B19 INFECTION AND FROM THOSE WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

      Arthritis and rheumatism
    57. MORLEY BJ; HOGARTH MB; SLINGSBY JH; ALLEN PJ; ROSE SJ; THOMPSON EM; CHANDLER P; DAVIES KA; SIMPSON E; WALPORT MJ
      IDENTIFICATION OF MULTIPLE LUPUS SUSCEPTIBILITY LOCI IN BXSB MICE

      American journal of human genetics
    58. ALLEN AR; SCOTT J; CLUTTERBUCK E; WALPORT MJ; DAVIES K; WILDING J; THOMPSON M
      REACTIVE (AA) SYSTEMIC AMYLOIDOSIS - A CAUSE OF REFRACTORY NEPHROTIC SYNDROME

      BMJ. British medical journal
    59. SLINGSBY JH; DYSON PJ; MORLEY BJ; WALPORT MJ; SIMPSON E
      LOCALIZATION OF MTV44 TO THE CENTROMERIC REGION OF MOUSE CHROMOSOME-11

      Mammalian genome
    60. WALPORT MJ; DAVIES KA
      COMPLEMENT AND IMMUNE-COMPLEXES

      Research in immunology
    61. SLINGSBY JH; HOGARTH MB; SIMPSON E; WALPORT MJ; MORLEY BJ
      NEW MICROSATELLITE POLYMORPHISMS IDENTIFIED BETWEEN C57BL 6, C57BL/10, AND C57BL/KSJ INBRED MOUSE STRAINS/

      Immunogenetics
    62. TOPALOGLU R; BAKKALOGLU A; SLINGSBY JH; MIHATSCH MJ; PASCUAL M; NORSWORTHY P; MORLEY BJ; SAATCI U; SCHIFFERLI JA; WALPORT MJ
      MOLECULAR-BASIS OF HEREDITARY C1Q DEFICIENCY ASSOCIATED WITH SLE AND IGA NEPHROPATHY IN A TURKISH FAMILY

      Kidney international
    63. NAUGHTON MA; BOTTO M; CARTER MJ; ALEXANDER GJM; GOLDMAN JM; WALPORT MJ
      EXTRAHEPATIC SECRETED COMPLEMENT C3 CONTRIBUTES TO CIRCULATING C3 LEVELS IN HUMANS

      The Journal of immunology
    64. MITCHELL TJ; NAUGHTON M; NORSWORTHY P; DAVIES KA; WALPORT MJ; MORLEY BJ
      IFN-GAMMA UP-REGULATES EXPRESSION OF THE COMPLEMENT COMPONENTS C3 ANDC4 BY STABILIZATION OF MESSENGER-RNA

      The Journal of immunology
    65. VYSE TJ; MORLEY BJ; BARTOK I; THEODORIDIS EL; DAVIES KA; WEBSTER ADB; WALPORT MJ
      THE MOLECULAR-BASIS OF HEREDITARY COMPLEMENT FACTOR-I DEFICIENCY

      The Journal of clinical investigation
    66. MITCHELL TJ; VAISHNAW AK; ROSE SJ; WALPORT MJ; MORLEY BJ
      TISSUE-SPECIFIC TRANSCRIPTIONAL CONTROL OF THE HUMAN-COMPLEMENT C4 GENE IS DIRECTED BY THE FIRST 126BP OF THE PROMOTER

      Immunology
    67. NAUGHTON MA; WALPORT MJ; WURZNER R; CARTER MJ; ALEXANDER GJM; GOLDMAN JM; BOTTO M
      ORGAN-SPECIFIC CONTRIBUTION TO CIRCULATING C7 LEVELS BY THE BONE-MARROW AND LIVER IN HUMANS

      European Journal of Immunology
    68. HOGARTH MB; NORSWORTHY PJ; ALLEN PJ; TRINDER PKE; LOOS M; MORLEY BJ; WALPORT MJ; DAVIES KA
      AUTOANTIBODIES TO THE COLLAGENOUS REGION OF C1Q OCCUR IN 3 STRAINS OFLUPUS-PRONE MICE

      Clinical and experimental immunology
    69. BOTTTO M; THEODORIDIS E; THOMPSON EM; BEYNON HLC; BRIGGS D; ISENBERG DA; WALPORT MJ; DAVIES KA
      FC-GAMMA-RIIA POLYMORPHISM IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - NOASSOCIATION WITH DISEASE

      Clinical and experimental immunology
    70. SLINGSBY JH; NORSWORTHY P; PEARCE G; VAISHNAW AK; ISSLER H; MORLEY BJ; WALPORT MJ
      HOMOZYGOUS HEREDITARY CLQ DEFICIENCY AND SYSTEMIC LUPUS-ERYTHEMATOSUS- A NEW FAMILY AND THE MOLECULAR-BASIS OF CLQ DEFICIENCY IN 3 FAMILIES

      Arthritis and rheumatism
    71. HARMER IJ; SO AKL; WALPORT MJ; MACKWORTHYOUNG C; THOMPSON KM
      MONOCLONAL ANTIPHOSPHOLIPID ANTIBODIES AND GERMLINE V-H GENES - REPLY

      Arthritis and rheumatism
    72. HALL FC; KRAUSZ T; WALPORT MJ
      IDIOPATHIC EOSINOPHILIC MYOSITIS

      Quarterly Journal of Medicine
    73. JARMAN PR; WALPORT MJ; PRIDE NB; HUGHES JMB; SCADDING JG; FRACKOWIAK RS; PETERS AM
      GRAND ROUNDS - HAMMERSMITH-HOSPITAL - MENINGEAL GRANULOMAS - SARCOIDOSIS OR TUBERCULOSIS

      BMJ. British medical journal
    74. DAVIE CA; FEINSTEIN A; KARTSOUNIS LD; BARKER GJ; MCHUGH NJ; WALPORT MJ; RON MA; MOSELEY IF; MCDONALD WI; MILLER DH
      PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF SYSTEMIC LUPUS-ERYTHEMATOSUS INVOLVING THE CENTRAL-NERVOUS-SYSTEM

      Journal of neurology
    75. MARGUERIE C; KAYE S; VYSE T; MACKWORTHYOUNG C; WALPORT MJ; BLACK C
      MALABSORPTION CAUSED BY CELIAC-DISEASE IN PATIENTS WHO HAVE SCLERODERMA

      British journal of rheumatology
    76. MACKWORTHYOUNG CG; ANDREOTTI F; HARMER I; LOIZOU S; POTTINGER BE; PEARSON JD; DAVIES GJ; MASERI A; WALPORT MJ
      ENDOTHELIUM-DERIVED HEMOSTATIC FACTORS AND THE ANTIPHOSPHOLIPID SYNDROME

      British journal of rheumatology
    77. DAVIES KA; IRELAND H; ATHANASSIOU P; LOIZOU S; LANE D; WALPORT MJ
      FACTOR-V LEIDEN MUTATION AND VENOUS THROMBOSIS

      Lancet
    78. VAISHNAW AK; HARGREAVES R; CAMPBELL RD; MORLEY BJ; WALPORT MJ
      DNASE I HYPERSENSITIVITY MAPPING AND PROMOTER POLYMORPHISM ANALYSIS OF HUMAN C4

      Immunogenetics
    79. DAVIES KA; CHAPMAN PT; NORSWORTHY PJ; JAMAR F; ATHANASSIOU P; KEELAN ETM; HARRISON AA; BINNS RM; HASKARD DO; WALPORT MJ
      CLEARANCE PATHWAYS OF SOLUBLE IMMUNE-COMPLEXES IN THE PIG - INSIGHTS INTO THE ADAPTIVE NATURE OF ANTIGEN CLEARANCE IN HUMANS

      The Journal of immunology
    80. BARTOK I; WALPORT MJ
      COMPARISON OF THE BINDING OF C3S AND C3F TO COMPLEMENT RECEPTORS TYPE-1, TYPE-2, AND TYPE-3

      The Journal of immunology
    81. SEELEN MA; ATHANASSIOU P; LYNN WA; NORSWORTHY P; WALPORT MJ; COHEN J; DAVIES KA
      THE ANTI-LIPID-A MONOCLONAL-ANTIBODY E5 BINDS TO ROUGH GRAM-NEGATIVE BACTERIA, FIXES C3, AND FACILITATES BINDING OF BACTERIAL IMMUNE-COMPLEXES TO BOTH ERYTHROCYTES AND MONOCYTES

      Immunology
    82. DAVIES KA; COPE AP; SCHOFIELD JB; CHU CQ; MASON JC; KRAUSZ T; SMITH P; DENMAN AM; WALPORT MJ
      A RARE MEDIASTINAL TUMOR PRESENTING WITH SYSTEMIC EFFECTS DUE TO IL-6AND TUMOR-NECROSIS-FACTOR (TNF) PRODUCTION

      Clinical and experimental immunology
    83. ALDRIDGE HD; WALPORT MJ
      ETHICAL ISSUES IN CLINICAL RESEARCH - THE ROLE OF THE RESEARCH ETHICSCOMMITTEE

      British Journal of Urology
    84. DAVIES KA; THEODORIDIS E; BOTTO M; THOMPSON EM; ISENBERG DA; BRIGGS D; BEYNON HLC; WALPORT MJ
      IGA FC-GAMMA-IIA (CD32) POLYMORPHISM IN SLE - GENOTYPIC ANALYSIS IN CAUCASIAN AND AFRO-CARIBBEAN PATIENTS

      Arthritis and rheumatism
    85. SLINGSBY JH; PEARCE GJ; NORSWORTHY PJ; DAVIES KA; ISSLER H; MORLEY BJ; WALPORT MJ
      MOLECULAR-BASIS OF COMPLETE FUNCTIONAL C1Q DEFICIENCY IN 3 PATIENTS

      Arthritis and rheumatism
    86. HOGARTH MB; MORLEY BJ; ALLEN PJ; SLINGSBY JH; SIMPSON E; DAVIES KA; WALPORT MJ
      THE EFFECT OF DOMINANT SUSCEPTIBILITY GENES ON PHENOTYPE IN BXSB LUPUS-PRONE MICE

      Arthritis and rheumatism
    87. DAVIES KA; NORSWORTHY P; WALPORT MJ
      ANTI-C1Q ANTIBODIES ARE ASSOCIATED WITH HYPO-COMPLEMENTAEMIA, DEFECTIVE OPSONIZATION OF GRAM-POSITIVE ORGANISMS, AND DEATH DUE TO INFECTIONIN PATIENTS WITH SLE

      Arthritis and rheumatism
    88. LOIZOU S; CAZABON JK; SO AKL; TAIT D; WALPORT MJ
      ANTIPHOSPHOLIPID ANTIBODIES FROM PATIENTS INFECTED WITH HUMAN B19 PARVOVIRUS HAVE SIMILAR SPECIFICITY AND COFACTOR DEPENDENCE TO THOSE FOUND IN SLE PATIENTS

      Arthritis and rheumatism
    89. HARMER IJ; LOIZOU S; THOMPSON KM; SO AKL; WALPORT MJ; MACKWORTHYOUNG C
      A HUMAN MONOCLONAL ANTIPHOSPHOLIPID ANTIBODY THAT IS REPRESENTATIVE OF SERUM ANTIBODIES AND IS GERMLINE ENCODED

      Arthritis and rheumatism
    90. BOWNESS P; DAVIES KA; NORSWORTHY PJ; ATHANASSIOU P; TAYLORWIEDEMAN J; BORYSIEWICZ LK; MEYER PAR; WALPORT MJ
      HEREDITARY C1Q DEFICIENCY AND SYSTEMIC LUPUS-ERYTHEMATOSUS

      Quarterly Journal of Medicine
    91. VYSE TJ; SPATH PJ; DAVIES KA; MORLEY BJ; PHILIPPE P; ATHANASSIOU P; GILES CM; WALPORT MJ
      HEREDITARY COMPLEMENT FACTOR-I DEFICIENCY

      Quarterly Journal of Medicine
    92. WALPORT MJ; DAVIES KA; BOTTO M; NAUGHTON MA; ISENBERG DA; BIASI D; POWELL RJ; CHEUNG NT; STRUTHERS GR
      C3 NEPHRITIC FACTOR AND SLE - REPORT OF 4 CASES AND REVIEW OF THE LITERATURE

      Quarterly Journal of Medicine
    93. CLESHAM GJ; SCOTT J; OAKLEY CM; MCCARTHY A; WALPORT MJ; HUGHES JMB; SILVERMAN M
      BETA-ADRENERGIC AGONISTS AND PULMONARY-EDEMA IN PRETERM LABOR

      BMJ. British medical journal
    94. DAVIES KA; BEYNON HLC; WALPORT MJ
      LONG-TERM MANAGEMENT AFTER SPLENECTOMY - CONSIDER PROPHYLAXIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS

      BMJ. British medical journal
    95. VYSE TJ; BATES GP; WALPORT MJ; MORLEY BJ
      THE ORGANIZATION OF THE HUMAN-COMPLEMENT FACTOR-I GENE (IF) - A MEMBER OF THE SERINE-PROTEASE GENE FAMILY

      Genomics
    96. DAVIES KA; SCHIFFERLI JA; WALPORT MJ
      COMPLEMENT DEFICIENCY AND IMMUNE-COMPLEX DISEASE

      Perspectives in mathematical logic
    97. WEBSTER G; BEYNON HLC; WALPORT MJ
      JAW CLAUDICATION AND AMAUROSIS FUGAX SECONDARY TO ATHEROMATOUS DISEASE OF THE CAROTID ARTERIES

      British journal of rheumatology
    98. ROBSON MG; WALPORT MJ; DAVIES KA
      SYSTEMIC LUPUS-ERYTHEMATOSUS AND ACUTE DEMYELINATING POLYNEUROPATHY

      British journal of rheumatology
    99. VYSE T; LUXON LM; WALPORT MJ
      AUDIOVESTIBULAR MANIFESTATIONS OF THE ANTIPHOSPHOLIPID SYNDROME

      Journal of Laryngology and Otology
    100. BEYNON HLC; DAVIES KA; HASKARD DO; WALPORT MJ
      ERYTHROCYTE COMPLEMENT RECEPTOR-TYPE-1 AND INTERACTIONS BETWEEN IMMUNE-COMPLEXES, NEUTROPHILS, AND ENDOTHELIUM

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 22:08:09